Nevro Corp. (NYSE:NVRO) Receives $6.43 Consensus Target Price from Brokerages
Nevro Corp. (NYSE:NVRO – Get Free Report) has earned a consensus rating of “Reduce” from the thirteen research firms that are ...
Hosted on MSN28d
Globus Medical to acquire Nevro for $250 million
Nevro will not hold an earnings call or provide 2025 guidance due to the pending acquisition. Morgan Stanley (NYSE:MS) & Co. LLC and Wyrick Robbins Yates & Ponton LLP are advising Globus Medical ...
Yahoo Finance9d
Nevro Q4 Earnings & Revenues Beat Estimates, Gross Margin Down
Nevro Corp. NVRO reported a loss per share of 64 cents in the fourth quarter of 2024, wider than the year-ago quarter’s loss of 15 cents. The Zacks Consensus Estimate is pegged at a loss per ...
WTOP News10d
Nevro: Q4 Earnings Snapshot
REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Nevro Corp. (NVRO) on Tuesday reported a loss of $53.1 million in its fourth quarter. On a per-share basis, the Redwood City ...
Morningstar10d
Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results
REDWOOD CITY, Calif., March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic ...
Yahoo Finance11d
Nevro Corp (NVRO) Q4 2024 Earnings Report Preview: What To Expect
Nevro Corp (NYSE:NVRO) is set to release its Q4 2024 earnings on Mar 4, 2025. The consensus estimate for Q4 2024 revenue is $102.54 million, and the earnings are expected to come in at -$0.79 per ...